9524311000001108: Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\UK product\Virtual medicinal product\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\UK product\Virtual therapeutic moiety\Agalsidase beta\Product containing only agalsidase beta in parenteral dose form (medicinal product form)\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\UK product\Virtual therapeutic moiety\Agalsidase beta\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\UK product\Trade family\Fabrazyme\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme\Product containing hydrolase (product)\Product containing agalsidase beta\Agalsidase beta\Product containing only agalsidase beta in parenteral dose form (medicinal product form)\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme\Product containing hydrolase (product)\Product containing agalsidase beta\Agalsidase beta\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme\Product containing hydrolase (product)\Product containing agalsidase beta\Product containing agalsidase beta in parenteral dose form (medicinal product form)\Product containing only agalsidase beta in parenteral dose form (medicinal product form)\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing agalsidase beta\Agalsidase beta\Product containing only agalsidase beta in parenteral dose form (medicinal product form)\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing agalsidase beta\Agalsidase beta\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing agalsidase beta\Product containing agalsidase beta in parenteral dose form (medicinal product form)\Product containing only agalsidase beta in parenteral dose form (medicinal product form)\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)
\Medicinal product\Product manufactured as parenteral dose form\Product containing agalsidase beta in parenteral dose form (medicinal product form)\Product containing only agalsidase beta in parenteral dose form (medicinal product form)\Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection\Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1953451000001119 Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1953461000001116 Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Is a	Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has active ingredient	Alpha-galactosidase	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has active ingredient	Biological agent	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has active ingredient	Agalsidase beta	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has active ingredient	Beta-galactosidase	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has manufactured dose form	Powder for conventional release solution for injection	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Is a	Fabrazyme	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has specific active ingredient	Agalsidase beta	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has active ingredient	Agalsidase beta	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has dispensed dose form	Powder for infusion solution	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has manufactured dose form	Injection	false	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has specific active ingredient	Agalsidase beta	true	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial	Is pack of	False	Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial	Has AMP	True	Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1953451000001119	Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1953461000001116	Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module